Cover Image

Fabrication and Preliminary In Vitro Evaluation of 3D-Printed Alginate Films with Cannabidiol (CBD) and Cannabigerol (CBG) Nanoparticles for Potential Wound-Healing Applications

In this study, drug carrier nanoparticles comprised of Pluronic-F127 and cannabidiol (CBD) or cannabigerol (CBG) were developed, and their wound healing action was studied. They were further incorporated in 3D printed films based on sodium alginate. The prepared films were characterized morphologica...

Full description

Saved in:

Bibliographic Details
Main Authors:	Paraskevi Kyriaki Monou (Author), Anastasia Maria Mamaligka (Author), Emmanuil K. Tzimtzimis (Author), Dimitrios Tzetzis (Author), Souzan Vergkizi-Nikolakaki (Author), Ioannis S. Vizirianakis (Author), Eleftherios G. Andriotis (Author), Georgios K. Eleftheriadis (Author), Dimitrios G. Fatouros (Author)
Format:	Book
Published:	MDPI AG, 2022-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development and Characterization of Inkjet Printed Edible Films for Buccal Delivery of B-Complex Vitamins
by: Georgios Eleftheriadis, et al.
Published: (2020)

Development of Bio-Active Patches Based on Pectin for the Treatment of Ulcers and Wounds Using 3D-Bioprinting Technology
by: Eleftherios G. Andriotis, et al.
Published: (2020)

A randomized, double-blind, placebo-controlled, repeated-dose pilot study of the safety, tolerability, and preliminary effects of a cannabidiol (CBD)- and cannabigerol (CBG)-based beverage powder to support recovery from delayed onset muscle soreness (DOMS)
by: Erica N. Peters, et al.
Published: (2023)

The use of cannabidiol (CBD) as an analgesic component
by: Kristian Kjær-Staal Petersen, et al.
Published: (2023)

Towards Better Delivery of Cannabidiol (CBD)
by: Sophie Anne Millar, et al.
Published: (2020)

Electrospun Orodispersible Films of Isoniazid for Pediatric Tuberculosis Treatment
by: Konstantina Chachlioutaki, et al.
Published: (2020)

Antibiofilm and Immune-Modulatory Activity of Cannabidiol and Cannabigerol in Oral Environments-In Vitro Study
by: Hernan Santiago Garzón, et al.
Published: (2024)

The Anti-Inflammatory Effects of Cannabidiol (CBD) on Acne
by: Peyravian N, et al.
Published: (2022)

Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders
by: Baswan SM, et al.
Published: (2020)

Impact of smoking cannabidiol (CBD)-rich marijuana on driving ability
by: Tim J. Gelmi, et al.
Published: (2021)

Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis
by: Christopher J Failing, et al.
Published: (2021)

Neuroprotective and Neuromodulatory Effects Induced by Cannabidiol and Cannabigerol in Rat Hypo-E22 cells and Isolated Hypothalamus
by: Viviana di Giacomo, et al.
Published: (2020)

Solid Dosage Forms of Dexamethasone Sodium Phosphate Intended for Pediatric Use: Formulation and Stability Studies
by: Maria S. Synaridou, et al.
Published: (2020)

Current state of knowledge on the use of cannabidiol (CBD) in various medical conditions
by: Zuzanna Lubczyńska, et al.
Published: (2023)

Cannabidiol in sports: insights on how CBD could improve performance and recovery
by: Daniel Rojas-Valverde, et al.
Published: (2023)

Cannabidiol (CBD) Supports the Honeybee Worker Organism by Activating the Antioxidant System
by: Patrycja Skowronek, et al.
Published: (2023)

Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer
by: Uchini S. Kosgodage, et al.
Published: (2018)

Cannabidiol (CBD): A Systematic Review of Clinical and Preclinical Evidence in the Treatment of Pain
by: Guillermo Cásedas, et al.
Published: (2024)

Cannabidiol (CBD) Alters the Functionality of Neutrophils (PMN). Implications in the Refractory Epilepsy Treatment
by: Claudia Taborda Gómez, et al.
Published: (2021)

Label accuracy of unregulated cannabidiol (CBD) products: measured concentration vs. label claim
by: Erin Johnson, et al.
Published: (2022)

Mucoadhesion and Mucopenetration of Cannabidiol (CBD)-Loaded Mesoporous Carrier Systems for Buccal Drug Delivery
by: Ulrike Söpper, et al.
Published: (2021)

Staff awareness of the use of cannabidiol (CBD): a trust-wide survey study in the UK
by: Obioha Ukaegbu, et al.
Published: (2021)

Primary care provider attitudes, experiences and practices about cannabidiol (CBD) and barriers to patient-provider communication about CBD use: A qualitative study
by: Pravesh Sharma, et al.
Published: (2022)

Total cannabidiol (CBD) concentrations and yields from traditional extraction methods: Percolation vs. maceration
by: Jason Wilson, et al.
Published: (2022)

Bioactive Properties and In Vitro Digestive Release of Cannabidiol (CBD) from Tailored Composites Based on Carbon Materials
by: Karol Zapata, et al.
Published: (2024)

Attitudes, beliefs, and changing trends of cannabidiol (CBD) oil use among caregivers of individuals with Alzheimer's disease
by: Magdalena Leszko, et al.
Published: (2021)

Stable Isotope Ratio Analysis for Authentication of Natural Antioxidant Cannabidiol (CBD) from <i>Cannabis sativa</i>
by: Matteo Perini, et al.
Published: (2023)

Protocol for a pragmatic trial of Cannabidiol (CBD) to improve chronic pain symptoms among United States Veterans
by: Rachel S. Bergmans, et al.
Published: (2024)

UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD Formulations
by: Sara Malaca, et al.
Published: (2021)

The Advent of a New Era in Digital Healthcare: A Role for 3D Printing Technologies in Drug Manufacturing?
by: Ioannis I. Andreadis, et al.
Published: (2022)

Correction: Andreadis et al. The Advent of a New Era in Digital Healthcare: A Role for 3D Printing Technologies in Drug Manufacturing? <i>Pharmaceutics</i> <b>2022</b>, <i>14</i>, 609
by: Ioannis I. Andreadis, et al.
Published: (2022)

A comparison of advertised versus actual cannabidiol (CBD) content of oils, aqueous tinctures, e-liquids and drinks purchased in the UK
by: Drusus A. Johnson, et al.
Published: (2023)

Regulatory Effect of Cannabidiol (CBD) on Decreased β-Catenin Expression in Alopecia Models by Testosterone and PMA Treatment in Dermal Papilla Cells
by: Yoon-Jong Park, et al.
Published: (2021)

Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems
by: Julie Moltke, et al.
Published: (2021)

Oral cannabidiol (CBD) as add-on to paracetamol for painful chronic osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trialResearch in context
by: Sibylle Pramhas, et al.
Published: (2023)

In silico molecular mechanism of cannabigerol as a cyclooxygenase-2 inhibitor
by: Muhammad Abdullah Shah, et al.
Published: (2013)

Chronic Cannabigerol as an Effective Therapeutic for Cisplatin-Induced Neuropathic Pain
by: Rahul Nachnani, et al.
Published: (2023)

Effect of aerosolized nicotine on human bronchial epithelial cells is amplified after co-administration with cannabidiol (CBD): a pilot in vitro study
by: Noel J. Leigh, et al.
Published: (2020)

CBD What Does the Science Say?
by: Parker, Linda A.
Published: (2022)

Chemotherapy‐induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol
by: Daniel I. Brierley, et al.
Published: (2019)